Recovery of Baseline Erectile Function in Men Following Radical Prostatectomy for High-Risk Prostate Cancer: A Prospective Analysis Using Validated Measures.

Published on Mar 1, 2016in The Journal of Sexual Medicine3.802
· DOI :10.1016/J.JSXM.2016.01.005
J.D. Kelly44
Estimated H-index: 44
(UCL: University College London)
Sources
Abstract
Abstract Introduction Recovery of baseline erectile function (EF) after robotic radical prostatectomy in men with high-risk prostate cancer is under-reported. Published studies have selectively reported on low-risk disease using non-validated and poorly defined thresholds for EF recovery. Aim To assess return to baseline EF in men after robotic radical prostatectomy for high-risk prostate cancer. Materials Five hundred thirty-one men underwent robotic radical prostatectomy for high-risk prostate cancer from February 2010 through July 2014. Pre- and postoperative EF was prospectively assessed using the International Index of Erectile Dysfunction (IIEF-5) questionnaire. Multivariate logistic regression analysis determined the effect of age, preoperative function, comorbidities, body mass index, prostate-specific antigen level, cancer stage or grade, nerve-sparing status, adjuvant therapy, and continence on EF return (defined as postoperative return to baseline EF with or without use of phosphodiesterase type 5 inhibitors). Kaplan-Meier analysis and log-rank test were used to analyze return over time. Mann-Whitney U-test was used to compare IIEF-5 scores. Main Outcome Measures Pre- and postoperative EF was assessed using the IIEF-5 Sexual Health Inventory for Men at 3 months, 6 months, 1 year, 2 years, 3 years, and 4 years postoperatively. Results Overall, return of EF was seen in 23.5% of patients at 18 months. This was significantly increased in men no older than 60 years ( P  = .024), with a preoperative IIEF-5 score of at least 22 ( P  = .042), and after undergoing neurovascular bundle preservation (34.9% of patients, P P  = .87), although there was significant improvement in those receiving second- or third-line therapies ( P  = .042). Other than preoperative hypertension ( P  = .03), none of the other comorbidities predicted return of EF. Conclusion In this study, 23.5% of men recovered to baseline EF. Of those who underwent bilateral neurovascular bundle preservation robotic radical prostatectomy, 70% recovered baseline EF; however, this accounted for only 9.6% of all patients. Only 4% of men who underwent non-neurovascular bundle preservation had baseline recovery with phosphodiesterase type 5 inhibitors up to 36 months. There was significant improvement after use of second- or third-line therapies, indicating the need for earlier institution of these treatment modalities.
📖 Papers frequently viewed together
References33
Newest
#1Carrie Stewart (Tulane University)H-Index: 5
#2Faysal A. Yafi (Tulane University)H-Index: 24
Last. Wayne J.G. Hellstrom (Tulane University)H-Index: 2
view all 9 authors...
Purpose: Collagenase clostridium histolyticum is the only FDA (Food and Drug Administration) approved treatment for Peyronie's disease. However, to our knowledge collagenase clostridium histolyticum has not been studied in men with ventral plaques. Given this limitation and the paucity of literature on ventral plaque outcomes, we compared the results of Peyronie's disease treatment in men with different plaque locations treated with intralesional interferon-α2b.Materials and Methods: We retrospe...
Source
#1Ajay Nehra (American Urological Association)H-Index: 55
#2Ralph Alterowitz (American Urological Association)H-Index: 1
Last. Arthur L. Burnett (American Urological Association)H-Index: 85
view all 15 authors...
Purpose: The purpose of this guideline is to provide a clinical framework for the diagnosis and treatment of Peyronie’s disease.Materials and Methods: A systematic review of the literature using the PubMed®, EMBASE® and Cochrane databases (search dates 1/1/1965 to 1/26/15) was conducted to identify peer-reviewed publications relevant to the diagnosis and treatment of PD. The review yielded an evidence base of 303 articles after application of inclusion/exclusion criteria.Results: The systematic ...
Source
#6J.D. Kelly (UCL: University College London)H-Index: 44
Abstract Background National Health Service England recently oversaw a whole-scale reconfiguration of cancer services in London, UK, for a number of different cancer pathways. Centralisation of cancer surgery has occurred with prostate cancer (PCa) surgery only being commissioned at a single designated pelvic cancer surgical centre. This process has required surgeons to work in teams providing a hub-and-spoke model of care. Objective To report the extent to which the initiation of a quality assu...
Source
#1Alexander Laird (Western General Hospital)H-Index: 12
#2Sarah FowlerH-Index: 9
Last. S. Alan McNeill (Western General Hospital)H-Index: 15
view all 8 authors...
Objective To determine current radical prostatectomy (RP) practice in the UK and compare surgical outcomes between techniques. Patients and Methods All RPs performed between 1 January 2011 and 31 December 2011 in the UK with data entered into the British Association of Urological Surgeons (BAUS) database, were identified for analysis. Overall surgical outcomes were assessed and subgroup analyses of these outcomes, based on operative technique [open RP (ORP), laparoscopic RP (LRP) and robot-assis...
Source
#1J. Devos (UGent: Ghent University)H-Index: 1
#2C. Van Praet (UGent: Ghent University)H-Index: 5
Last. Nicolaas Lumen (UGent: Ghent University)H-Index: 30
view all 9 authors...
AbstractBackground:Men diagnosed with localised prostate cancer have to make a well-informed treatment choice between (robot-assisted) radical prostatectomy, external beam radiotherapy and, in selected cases, brachytherapy and active surveillance. We developed and validated a questionnaire to determine the cognitive reasons motivating this choice.Materials and methods:The Prostate Cancer Decision-Making Questionnaire (PC-DMQ) was designed in-house and validated through the Delphi method. Finally...
Source
#1R. Krishnan (MSK: Memorial Sloan Kettering Cancer Center)H-Index: 1
#2Darren J. Katz (MSK: Memorial Sloan Kettering Cancer Center)H-Index: 15
Last. John P. Mulhall (MSK: Memorial Sloan Kettering Cancer Center)H-Index: 79
view all 4 authors...
Summary Few studies have looked at erectile function recovery (EFR) rates in men undergoing non-nerve sparing resection during radical prostatectomy (RP). Existing studies show great variation in EFR rates owing to multiple factors that minimize their utility in counselling RP patients. We investigated the EFR rate and its predictors in unilateral cavernous nerve resection and bilateral cavernous nerve resection patients 24 months after RP. We conducted a population-based, prospective cohort stu...
Source
#1Bong Hee Park (SMC: Samsung Medical Center)H-Index: 9
#2Hwang Gyun Jeon (SMC: Samsung Medical Center)H-Index: 11
Last. Seong Soo Jeon (SMC: Samsung Medical Center)H-Index: 27
view all 7 authors...
Purpose: We evaluated the accuracy of preoperative multiparametric 3.0-T magnetic resonance imaging for local staging of prostate cancer and its influence in the decision to preserve neurovascular bundles at robotic assisted laparoscopic radical prostatectomy.Materials and Methods: The study included 353 patients who had confirmed prostate cancer and underwent preoperative magnetic resonance imaging and robotic assisted laparoscopic radical prostatectomy between 2008 and 2011. The extent of neur...
Source
#1James Thompson (UNSW: University of New South Wales)H-Index: 23
#2Sam Egger (Cancer Council New South Wales)H-Index: 20
Last. Phillip D. Stricker (UNSW: University of New South Wales)H-Index: 57
view all 7 authors...
Abstract Background Comparative studies suggest functional and perioperative superiority of robot-assisted radical prostatectomy (RARP) over open radical prostatectomy (ORP). Objective To determine whether high-volume experienced open surgeons can improve their functional and oncologic outcomes with RARP and, if so, how many cases are required to surpass ORP outcomes and reach the learning curve plateau. Design, setting, and participants A prospective observational study compared two surgical te...
Source
#1Mikkel FodeH-Index: 19
#2Dana A. Ohl (UM: University of Michigan)H-Index: 34
Last. Jens SønksenH-Index: 34
view all 4 authors...
The pathophysiology of erectile dysfunction after radical prostatectomy (RP) is believed to include neuropraxia, which leads to temporarily reduced oxygenation and subsequent structural changes in penile tissue. This results in veno-occlusive dysfunction, therefore, penile rehabilitation programmes focus on tissue oxygenation. Animal studies support the use of phosphodiesterase type 5 inhibitors (PDE5Is) after cavernous nerve damage but results from human studies are contradictory. The largest s...
Source
#1Craig G. Rogers (Vattikuti Urology Institute)H-Index: 39
#2Jesse D. Sammon (Vattikuti Urology Institute)H-Index: 45
Last. Mani Menon (Vattikuti Urology Institute)H-Index: 94
view all 6 authors...
Abstract Objectives The role of robot assisted radical prostatectomy (RARP) for high-risk prostate cancer (CaP) is controversial, as is the role of RARP in elderly men. We evaluate outcomes of elderly patients with high-risk CaP who have chosen RARP over radiation or hormonal therapy. Materials and methods Between April 2001 and November 2009, 69 elderly patients (≥70 years) with high-risk CaP underwent RARP at our institution. High-risk CaP was defined using the D'Amico criterion, PSA ≥ 20 ng/m...
Source
Cited By22
Newest
#1Martin Hofmann (UCI: University of California, Irvine)H-Index: 4
#2Erica Huang (UCI: University of California, Irvine)H-Index: 1
Last. Thomas E. Ahlering (UCI: University of California, Irvine)H-Index: 58
view all 9 authors...
Abstract null null Background null During robotic-assisted radical prostatectomy (RARP), the use of electrocautery near the neurovascular bundles (NVBs) frequently results in thermal injury to the cavernous nerves. The cut and “touch” monopolar cautery technique has been suggested to reduce desiccating thermal injury caused by bipolar energy when vessels are sealed. null null null Objective null To compare potency outcomes between an athermal technique (AT) and touch cautery (TC) to transect the...
Source
#1Tomasz Jurys (University of Silesia in Katowice)
#2Bartlomiej Burzynski (University of Silesia in Katowice)H-Index: 1
Last. Andrzej Paradysz (University of Silesia in Katowice)H-Index: 13
view all 4 authors...
Erectile dysfunction is common postoperative complication after radical prostatectomy. The aim of this study is to evaluate erectile dysfunction among the population of men who have undergone radic...
Source
#1Nadja SchoentgenH-Index: 1
#2Gianluigi CalifanoH-Index: 6
Last. Paolo Verze (UNISA: University of Salerno)H-Index: 5
view all 9 authors...
Background and Purpose: Sexual dysfunction (SD) is a frequent side effect associated with radical prostatectomy (RP) for prostate cancer (PCa). Some studies have showed the benefit associated with preoperative sexual rehabilitation (prehabilitation) and Enhanced Recovery After Surgery (ERAS) for RP, but no clear clinical recommendations are available yet. Our aim was to conduct a systematic review on sexual prehabilitation prior to RP for patients with a localized PCa and analyze the impact on p...
Source
#1Arjun Nathan (University of Cambridge)H-Index: 1
#2Shivani Shukla (University of Cambridge)H-Index: 1
Last. Benjamin W LambH-Index: 2
view all 10 authors...
To assess whether the timing of post-operative Phosphodiesterase Inhibitor (PDE5i) therapy after Robot-Assisted Radical Prostatectomy (RARP) is associated with a change in early erectile function (EF) outcomes, continence or safety outcomes. Data were prospectively collected from a single surgeon in one tertiary centre. 158 patients were treated with PDE5i therapy post RARP over a 2-year period. PDE5i therapy was started: immediately (day 1-2) post-op in 29%, early (day 3-14) post-op in 37% and ...
Source
#1Claire Tonry (UCD: University College Dublin)H-Index: 6
#2Stephen P. Finn (Trinity College, Dublin)H-Index: 46
Last. Stephen R. Pennington (UCD: University College Dublin)H-Index: 31
view all 4 authors...
Following the introduction of routine Prostate Specific Antigen (PSA) screening in the early 1990′s, Prostate Cancer (PCa) is often detected at an early stage. There are also a growing number of treatment options available and so the associated mortality rate is generally low. However, PCa is an extremely complex and heterogenous disease and many patients suffer disease recurrence following initial therapy. Disease recurrence commonly results in metastasis and metastatic PCa has an average survi...
Source
#1Julie Wong (UBC: University of British Columbia)H-Index: 1
#2Luke Witherspoon (Ottawa Hospital)H-Index: 5
Last. Ryan Flannigan (Vancouver Prostate Centre)H-Index: 12
view all 12 authors...
Prostate cancer (PC) treatment leads to impairment of sexual function. The Prostate Cancer Supportive Care (PCSC) Program's Sexual Rehabilitation clinic (SRC) assists patients and their partners with sexual recovery using a biopsychosocial approach to rehabilitation. This study characterizes patients seen in the SRC between July 2013-1 July 2019. Data was retrospectively abstracted from clinic records. In total, 965 patients were seen over 3391 appointments during the study period. Median age (s...
Source
#1Catherine Catherine Lovegrove (Imperial College Healthcare)H-Index: 1
#2Vincenzo Ficarra (UNIME: University of Messina)H-Index: 16
Last. Suks Minhas (Imperial College Healthcare)H-Index: 31
view all 6 authors...
Patients with primary localised prostate cancer (PCa) have a wide choice of curative therapeutic interventions, including active surveillance, surgical, focal and radiation therapies. Based on clinical and oncological characteristics, treatment decisions entail consideration of oncological and functional outcomes with important effects on quality of life. We aimed to highlight evidence surrounding present inconsistencies, the problems this presents to clinicians and patients alike and the ration...
Source
#1Jun Nyung Lee (KNU: Kyungpook National University)H-Index: 12
#2Jae-Wook Chung (KNU: Kyungpook National University)H-Index: 8
Last. Tae Gyun Kwon (KNU: Kyungpook National University)H-Index: 24
view all 12 authors...
PurposePenile rehabilitation therapy using phosphodiesterase type 5 inhibitors (PDE5i) is used widely as a first-line therapy in patients with erectile dysfunction (ED) after radical prostatectomy (RP). However, many patients undergoing such therapy still complain of inappropriate erectile function (EF). Therefore, we evaluated the efficacy and safety of combined PDE5i therapy as a salvage medical treatment in patients nonresponsive to initial penile rehabilitation using daily PDE5i after nerve-...
Source
#8J.D. Kelly (UCL: University College London)H-Index: 44
Partial ablation of the prostate using high-intensity focussed ultrasound (HIFU-PA) is a treatment option for localised prostate cancer. When local recurrence occurs, salvage robot-assisted radical prostatectomy is a treatment option for selected patients, but there is a paucity of data on the peri-operative safety, functional and oncologic outcomes of sRARP.. The objective of this study was therefore to describe peri-operative safety, functional and early oncologic outcomes following salvage ro...
Source
#1Yongde Xu (Capital Medical University)H-Index: 1
#2Yong Yang (Chinese PLA General Hospital)H-Index: 2
Last. Ye Tian (Capital Medical University)H-Index: 14
view all 10 authors...
Abstract Background Intracavernous injection (ICI) of adipose-derived stem cells (ADSCs) has been demonstrated promising for neurogenic erectile dysfunction (ED). However, due to the sponge-like structure of corpus cavernosum (CC) with abundant vessels, ICI was indeed like intravenous injection. Thus, the cell escaping may be a concern of safety and limited therapy, but the issue has not been clearly demonstrated yet. Methods Suspensions of free ADSCs (FAs) and ADSCs-based spheroids (ASs) with s...
Source
This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.